EPA/DHA（オメガ3）成分の世界市場

EPA/DHA（オメガ3）成分の世界市場は2030年までに43億米ドルに達する見込み

2024年に31億米ドルと推定されるEPA/DHA（オメガ3）成分の世界市場は、2024年から2030年にかけてCAGR 5.6%で成長し、2030年には43億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるEPAは、CAGR6.4%を記録し、分析期間終了時には31億米ドルに達すると予想されます。DHAセグメントの成長率は、分析期間でCAGR 3.7%と推定されます。

米国市場は8億4,450万米ドルと推定、中国はCAGR 9.0％で成長すると予測

米国のEPA/DHA（オメガ3）成分市場は、2024年に8億4,450万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8億7,330万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と5.6%と予測されています。欧州では、ドイツがCAGR 3.6%で成長すると予測されています。

世界のEPA/DHA（オメガ3）成分市場- 主要動向と促進要因まとめ

なぜEPA/DHAオメガ3成分の需要が高まっているのか？

EPA（エイコサペンタエン酸）とDHA（ドコサヘキサエン酸）オメガ3成分の需要は、その健康効果に対する消費者の意識の高まりにより急増しています。これらの必須脂肪酸は、心臓血管の健康、認知機能、目の健康、炎症管理に重要な役割を果たしています。心臓病、神経疾患、肥満や糖尿病などの生活習慣病が増加していることから、消費者はオメガ3系を豊富に含む栄養補助食品や機能性食品を求めるようになっています。予防ヘルスケアの動向と個別化栄養学の台頭は、EPA/DHAベースの製品に対する需要をさらに押し上げています。

飲食品メーカーは、強化乳製品、乳児用調製粉乳、植物性代替食品など、さまざまな製品にオメガ3系成分を組み込んでいます。製薬業界も、特に心血管治療において、オメガ3ベースの医薬品ポートフォリオを拡大しています。藻類油のような植物由来の持続可能なオメガ3源へのシフトは、菜食主義者やベジタリアンの消費者に対応し、勢いを増しています。食生活の動向が機能的でクリーンラベルの原料を重視し続ける中、EPA/DHAオメガ3市場は力強い成長を遂げています。

調達と加工における技術革新は市場をどのように形成しているか？

オメガ3の抽出と精製における技術の進歩は、製品の品質と持続可能性を高めています。従来の魚油は依然としてEPAとDHAの一次情報源であるが、乱獲と海洋生態系の悪化が懸念され、代替情報源への投資が増加しています。藻類を原料とするオメガ3生産は、持続可能で環境に優しい選択肢として台頭してきており、純度が高く、海産魚によく見られる汚染物質を避けることができます。さらに、マイクロカプセル化技術によってオメガ3の安定性と生物学的利用能が向上し、より幅広い食品や飲食品への配合が可能になりつつあります。

製薬業界もまた、処方箋に基づく心臓血管治療用に、高濃度オメガ3エチルエステルやトリグリセリドなどの高度な製剤を開発しています。オメガ3系脂肪酸の健康効果を裏付ける規制当局の承認や臨床研究は、消費者の信頼と市場導入をさらに後押ししています。EPA/DHAオメガ3市場は、調達、加工、製剤化における技術革新が進むにつれて、さまざまな用途で持続的な成長と多様化が見込まれています。

EPA/DHA（オメガ3）成分市場の成長を促進する主な要因は何か？

EPA/DHA（オメガ3系）成分市場の成長は、消費者の健康意識の高まり、抽出・精製技術の進歩、医薬品、機能性食品、栄養補助食品における用途の拡大によって牽引されています。消費者が倫理的で環境に優しい製品を優先するため、持続可能な植物由来のオメガ3源に対する需要が高まっています。さらに、オメガ3類の健康上の利点を検証する科学研究の拡大は、規制当局の承認と製品開発に影響を及ぼしています。

製薬業界が心臓病管理、認知健康、炎症性疾患のためにオメガ3製剤への依存を高めていることも主要な促進要因です。個別化された栄養と的を絞った栄養補助食品の台頭は、オメガ3製品の提供におけるさらなる技術革新を促しています。持続可能性への投資の増加、技術改善、消費者意識の拡大により、EPA/DHAオメガ3市場は長期的に大きな成長が見込まれています。

セグメント

製品（EPA、DHA）、供給源（カタクチイワシ／イワシ油、高濃度、中濃度、低濃度、藻類油、マグロ油、タラ肝油、サーモン油、クリル油、メンヘデン油）、用途（栄養補助食品、機能性食品、医薬食品、幼児食品、その他）

調査対象企業の例

• Aker BioMarine AS
• Algarithm Ingredients
• Archer-Daniels-Midland Company
• Arista Industries Inc.
• BASF SE
• Cargill, Inc.
• Cellana Inc.
• Clover Corporation Ltd.
• Copeinca SAC
• Corbion NV

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従うのではなく、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global EPA / DHA (Omega 3) Ingredients Market to Reach US$4.3 Billion by 2030

The global market for EPA / DHA (Omega 3) Ingredients estimated at US$3.1 Billion in the year 2024, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. EPA, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the DHA segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$844.5 Million While China is Forecast to Grow at 9.0% CAGR

The EPA / DHA (Omega 3) Ingredients market in the U.S. is estimated at US$844.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$873.3 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global EPA/DHA (Omega-3) Ingredients Market - Key Trends & Drivers Summarized

Why Is the Demand for EPA/DHA Omega-3 Ingredients Rising?

The demand for EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) omega-3 ingredients is surging due to growing consumer awareness of their health benefits. These essential fatty acids play a critical role in cardiovascular health, cognitive function, eye health, and inflammation management. The increasing prevalence of heart disease, neurological disorders, and lifestyle-related conditions such as obesity and diabetes has prompted consumers to seek dietary supplements and functional foods enriched with omega-3s. The rise of preventive healthcare trends and personalized nutrition is further boosting the demand for EPA/DHA-based products.

Food and beverage manufacturers are incorporating omega-3 ingredients into various products, including fortified dairy, infant formula, and plant-based alternatives. The pharmaceutical industry is also expanding its omega-3-based drug portfolio, particularly in cardiovascular treatments. The shift toward plant-based and sustainable omega-3 sources, such as algal oil, is gaining momentum, catering to vegan and vegetarian consumers. As dietary trends continue to emphasize functional and clean-label ingredients, the EPA/DHA omega-3 market is experiencing robust growth.

How Are Innovations in Sourcing and Processing Shaping the Market?

Technological advancements in omega-3 extraction and purification are enhancing product quality and sustainability. Traditional fish oil remains the primary source of EPA and DHA, but concerns over overfishing and marine ecosystem degradation have led to increased investments in alternative sources. Algal-based omega-3 production is emerging as a sustainable and environmentally friendly option, offering high purity and avoiding contaminants commonly found in marine fish. Additionally, microencapsulation technologies are improving the stability and bioavailability of omega-3s, allowing for their incorporation into a broader range of food and beverage products.

The pharmaceutical industry is also developing advanced formulations, such as high-concentration omega-3 ethyl esters and triglycerides, for prescription-based cardiovascular treatments. Regulatory approvals and clinical research supporting the health benefits of omega-3 fatty acids are further driving consumer confidence and market adoption. As innovations in sourcing, processing, and formulation continue, the EPA/DHA omega-3 market is poised for sustained growth and diversification across various applications.

What Are the Key Factors Driving Growth in the EPA/DHA (Omega-3) Ingredients Market?

The growth in the EPA/DHA omega-3 ingredients market is driven by increasing consumer health consciousness, advancements in extraction and purification technologies, and expanding applications in pharmaceuticals, functional foods, and nutraceuticals. The demand for sustainable and plant-based omega-3 sources is rising as consumers prioritize ethical and environmentally friendly products. Additionally, the expansion of scientific research validating the health benefits of omega-3s is influencing regulatory approvals and product development.

The pharmaceutical industry's growing reliance on omega-3 formulations for heart disease management, cognitive health, and inflammatory disorders is another key driver. The rise of personalized nutrition and targeted dietary supplementation is encouraging further innovation in omega-3 product offerings. With increasing investments in sustainability, technological improvements, and expanding consumer awareness, the EPA/DHA omega-3 market is expected to experience significant long-term growth.

SCOPE OF STUDY:

The report analyzes the EPA / DHA (Omega 3) Ingredients market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (EPA, DHA); Source (Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil, Cod liver oil, Salmon oil, Krill oil, Menhaden oil); Application (Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Aker BioMarine AS
• Algarithm Ingredients
• Archer-Daniels-Midland Company
• Arista Industries Inc.
• BASF SE
• Cargill, Inc.
• Cellana Inc.
• Clover Corporation Ltd.
• Copeinca SAC
• Corbion NV

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • EPA / DHA (Omega 3) Ingredients - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Consumer Awareness of Heart and Brain Health Benefits Spurs Demand for Omega-3 Ingredients
  • Growing Preference for Plant-Based Omega-3 Sources Expands Addressable Market Opportunity
  • Accelerated Aging Population in Developed Economies Strengthens Business Case for Omega-3 Supplementation
  • Proliferation of Functional Foods and Beverages Generates Demand for EPA/DHA Fortification
  • Sports Nutrition Boom Propels Growth in High-Purity EPA/DHA Formulations
  • Regulatory Approvals for Health Claims in Key Markets Drives Adoption of Omega-3 Products
  • Increasing Incidence of Chronic Lifestyle Diseases Throws the Spotlight on Preventive Nutrition
  • Rising Vegan and Vegetarian Consumer Base Creates Opportunities for Algal-Sourced Omega-3s
  • Growing Focus on Maternal and Infant Health Accelerates Demand for DHA-Enriched Products
  • Innovation in Microencapsulation Technologies Enhances Stability and Drives Inclusion in Diverse Applications
  • Advancements in Aquaculture Feed Applications Expand Omega-3 Demand Beyond Human Nutrition
  • Shift Towards Clean-Label and Sustainable Ingredients Strengthens Market Penetration of Eco-Friendly Omega-3 Sources
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World EPA / DHA (Omega 3) Ingredients Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for EPA / DHA (Omega 3) Ingredients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for EPA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for EPA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for EPA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for DHA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for DHA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for DHA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Salmon oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Salmon oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Salmon oil by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Krill oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Krill oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Krill oil by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Menhaden oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Menhaden oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Menhaden oil by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Anchovy / Sardine Oils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Anchovy / Sardine Oils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Anchovy / Sardine Oils by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for High concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for High concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for High concentrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Medium Concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Medium Concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Medium Concentrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Low concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Low concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Low concentrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Algae oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Algae oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Algae oil by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Tuna oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Tuna oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Tuna oil by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Cod liver oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Cod liver oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Cod liver oil by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Dietary Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Dietary Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Dietary Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Functional Food by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Functional Food by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Functional Food by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Pharmaceutical Food by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Pharmaceutical Food by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Pharmaceutical Food by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Infant Food by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Infant Food by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Infant Food by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 56: USA Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 65: Canada Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Canada 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• JAPAN
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 74: Japan Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• CHINA
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• EUROPE
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 92: Europe Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for EPA / DHA (Omega 3) Ingredients by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• FRANCE
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 104: France Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• GERMANY
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 113: Germany Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 122: Italy Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 125: Italy Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 131: UK Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: UK Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: UK 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 134: UK Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: UK Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: UK 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 137: UK Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 140: Spain Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Spain Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Spain 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 143: Spain Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Spain Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Spain 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 146: Spain Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Spain Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Spain 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 149: Russia Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Russia Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Russia 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 152: Russia Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Russia Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Russia 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 155: Russia Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Russia Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Russia 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Rest of Europe Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Rest of Europe 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Rest of Europe Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Rest of Europe 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Rest of Europe Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Rest of Europe 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for EPA / DHA (Omega 3) Ingredients by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Asia-Pacific Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Asia-Pacific 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Asia-Pacific Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Asia-Pacific 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Asia-Pacific Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Asia-Pacific 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• AUSTRALIA
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 179: Australia Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Australia Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Australia 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 182: Australia Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Australia Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Australia 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 185: Australia Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Australia Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Australia 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• INDIA
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 188: India Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: India Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: India 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 191: India Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: India Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: India 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 194: India Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: India Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: India 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 197: South Korea Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: South Korea Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: South Korea 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 200: South Korea Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: South Korea Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: South Korea 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 203: South Korea Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: South Korea Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: South Korea 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Asia-Pacific Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Asia-Pacific 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 209: Rest of Asia-Pacific Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Rest of Asia-Pacific Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Rest of Asia-Pacific 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 212: Rest of Asia-Pacific Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Rest of Asia-Pacific Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Rest of Asia-Pacific 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for EPA / DHA (Omega 3) Ingredients by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 218: Latin America Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Latin America Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Latin America 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 221: Latin America Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Latin America Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Latin America 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 224: Latin America Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Latin America Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Latin America 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 227: Argentina Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Argentina Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Argentina 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 230: Argentina Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Argentina Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Argentina 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 233: Argentina Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Argentina Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Argentina 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 236: Brazil Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Brazil Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Brazil 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 239: Brazil Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Brazil Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Brazil 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 242: Brazil Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Brazil Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Brazil 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 245: Mexico Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Mexico Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Mexico 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 248: Mexico Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Mexico Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Mexico 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 251: Mexico Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Mexico Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Mexico 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Latin America Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Latin America 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 257: Rest of Latin America Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Latin America Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Rest of Latin America 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 260: Rest of Latin America Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Latin America Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Rest of Latin America 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for EPA / DHA (Omega 3) Ingredients by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 266: Middle East Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Middle East Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Middle East 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 269: Middle East Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Middle East Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Middle East 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 272: Middle East Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Middle East Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Middle East 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 275: Iran Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Iran Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Iran 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 278: Iran Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Iran Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Iran 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 281: Iran Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Iran Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Iran 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 284: Israel Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Israel Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Israel 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 287: Israel Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Israel Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Israel 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 290: Israel Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Israel Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Israel 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Saudi Arabia Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Saudi Arabia 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 296: Saudi Arabia Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Saudi Arabia Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Saudi Arabia 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 299: Saudi Arabia Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Saudi Arabia Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Saudi Arabia 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 302: UAE Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: UAE Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: UAE 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 305: UAE Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: UAE Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: UAE 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 308: UAE Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: UAE Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: UAE 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Middle East Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Middle East 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Middle East Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Middle East Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Middle East 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Middle East Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Middle East Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Middle East 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030
• AFRICA
  • EPA / DHA (Omega 3) Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 320: Africa Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Africa Historic Review for EPA / DHA (Omega 3) Ingredients by Product - EPA and DHA Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Africa 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Product - Percentage Breakdown of Value Sales for EPA and DHA for the Years 2015, 2025 & 2030
  • TABLE 323: Africa Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Africa Historic Review for EPA / DHA (Omega 3) Ingredients by Source - Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Africa 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Source - Percentage Breakdown of Value Sales for Salmon oil, Krill oil, Menhaden oil, Anchovy / Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil and Cod liver oil for the Years 2015, 2025 & 2030
  • TABLE 326: Africa Recent Past, Current & Future Analysis for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Africa Historic Review for EPA / DHA (Omega 3) Ingredients by Application - Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Africa 15-Year Perspective for EPA / DHA (Omega 3) Ingredients by Application - Percentage Breakdown of Value Sales for Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food and Others for the Years 2015, 2025 & 2030

IV. COMPETITION